Price Chart

Profile

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
URL https://www.livanova.com
Investor Relations URL https://investor.livanova.com
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 21, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
URL https://www.livanova.com
Investor Relations URL https://investor.livanova.com
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 21, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A